Grow your business safely with EUROFINS DEV BIOPHARMA FRANCE 3

All the information you need about EUROFINS DEV BIOPHARMA FRANCE 3 to develop and secure your business in France

E HOME > CORPORATES > EUROFINS DEV BIOPHARMA FRANCE 3 > BALANCE SHEET ( 2021-06-22)

THE LIST OF BALANCE SHEET : EUROFINS DEV BIOPHARMA FRANCE 3

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2022-06-22 Public 2021-12-31 Complete
2021-06-22 Public 2020-12-31 Complete
2020-11-25 Public 2019-12-31 Complete
2019-05-22 Public 2018-12-31 Complete
2018-06-11 Public 2017-12-31 Complete
NameEUROFINS PRODUCT TESTING 2 FRANCE HOLDING
Siren833456783
Closing2020-12-31
Registry code 4401
Registration number 12434
Management number2017B03194
Activity code 7120B
Closing date n-12019-12-31
Duration Fiscal year 12
Duration Fiscal year n-100
Filing date2021-06-22
Modification00 Annual accounts entered without anomaly
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPublic
Address44300 NANTES
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
BJ TOTAL (I) 12 210 157.00 12 210 157.00 12 210 157.00
BZ Other receivables 325 130.00 325 130.00 325 130.00
CF Cash and cash equivalents 19 537.00 19 537.00 19 537.00
CJ TOTAL (II) 344 667.00 344 667.00 344 667.00
CO Grand total (0 to V) 12 554 824.00 12 554 824.00 12 554 824.00
CU Other investments 12 210 157.00 12 210 157.00 12 210 157.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 5 205 000.00 5 205 000.00 5 205 000.00
DD Legal reserve (1) 9 881.00 9 881.00
DG Other reserves 187 744.00 187 744.00
DH Retained earnings -71 044.00
DI RESULTS FOR THE YEAR (Profit or Loss) -272 798.00 268 669.00 -272 798.00
DL TOTAL (I) 5 129 827.00 5 402 625.00 5 129 827.00
DV Miscellaneous Loans and Financial Debts (4) 7 423 430.00 7 423 430.00
DX Trade payables and related accounts 1 458.00 2 659.00 1 458.00
DY Tax and social security liabilities 109.00 109.00
EA Other liabilities 7 422 529.00
EC TOTAL (IV) 7 424 997.00 7 425 188.00 7 424 997.00
EE Grand total (I to V) 12 554 824.00 12 827 813.00 12 554 824.00
3 - Income statementAmount France year NAmount Export year NTotal year NTotal year N-1
FW Other purchases and external expenses 10 990.00
FX Taxes, duties, and similar payments
GF Total Operating Expenses (II) 10 990.00
GG - OPERATING RESULT (I - II) -10 990.00
GJ Financial income from other securities and fixed asset receivables
GM Reversals of provisions and transfers of expenses 1.00
GP Total financial income (V)
GR Interest and similar expenses 261 809.00
GU Total financial expenses (VI) 261 809.00
GV - FINANCIAL INCOME (V - VI) -261 809.00
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) -272 799.00
4 - Income statement (continued)Amount year NAmount year N-1
HL TOTAL REVENUE (I + III + V + VII) 569 669.00
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) 272 798.00 301 000.00 272 798.00
HN PROFIT OR LOSS (Total revenue - Total expenses) -272 798.00 268 669.00 -272 798.00
5 - Fixed assets increase - decreaseGross value at beginning of year - Item by itemRevaluation - DisposalsAcquisition - Gross value at year-end
0G ACQUISITIONS Total General Total 12 210 157.00 12 210 157.00
I3 DECREASES Total Financial Fixed Assets 12 210 157.00
I4 DECREASES Grand Total 12 210 157.00
LQ ACQUISITIONS Total Financial Fixed Assets 12 210 157.00 12 210 157.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
8A Miscellaneous Loans and Financial Debts 7 423 430.00 65 810.00 7 357 621.00 7 423 430.00
8B Suppliers and Related Accounts 1 456.00 1 456.00 1 456.00
VB VAT 109.00 109.00 109.00
VC Group and associates 325 000.00 325 000.00 325 000.00
VR Miscellaneous debtors (including receivables related to repo transactions) 21.00 21.00 21.00
VT TOTAL – STATEMENT OF RECEIVABLES 325 130.00 325 130.00 325 130.00
VW VAT 109.00 109.00 109.00
VY TOTAL – STATEMENT OF LIABILITIES 7 424 997.00 67 377.00 7 357 621.00 7 424 997.00

all companies in France

Complete and comprehensive database.